title: Quantification of biotherapeutic targets: new opportunities with immunoaffinity LC-MS/MS.
authors.affiliation: Pfizer Inc., Pfizer Worldwide Research & Development, Pharmacokinetics Dynamics & Metabolism, 1 Burtt Road, Andover, MA 01810, USA.
authors.forename: Hendrik
authors.initials: H
authors.lastname: Neubert
authors.forename: Joe
authors.initials: J
authors.lastname: Palandra
authors.forename: Mireia
authors.initials: M
authors.lastname: Fernández Ocaña
mesh_terms: D000906:Antibodies / Q000276:immunology; D002846:Chromatography, Affinity; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D008024:Ligands; D004364:Pharmaceutical Preparations / Q000032:analysis*; D011506:Proteins / Q000032:analysis / Q000276:immunology; D053719:Tandem Mass Spectrometry
chemical_list: D000906:Antibodies; D008024:Ligands; D004364:Pharmaceutical Preparations; D011506:Proteins
keywords: LC–MS/MS; bioanalysis; biotherapeutics; immunoaffinity; protein targets